nach oben

Reviews in Endocrine and Metabolic Disorders

Erschienen in:

01.06.2012

Methionine, homocysteine, one carbon metabolism and fetal growth

verfasst von: Satish C. Kalhan, Susan E. Marczewski

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Methionine and folate are the key components of one carbon metabolism, providing the methyl groups for numerous methyl transferase reactions via the ubiquitous methyl donor, s-adenosyl methionine. Methionine metabolism is responsive to nutrient intake, is regulated by several hormones and requires a number of vitamins (B12, pyridoxine, riboflavin) as co-factors. The critical relationship between perturbations in the mother’s methionine metabolism and its impact on fetal growth and development is now becoming evident. The relation of folate intake to fetal teratogenesis has been known for some time. Studies in human pregnancy show a continuous decrease in plasma homocysteine, and an increase in plasma choline concentrations with advancing gestation. A higher rate of transsulfuration of methionine in early gestation and of transmethylation in the 3rd trimester was seen in healthy pregnant women. How these processes are impacted by nutritional, hormonal and other influences in human pregnancy and their effect on fetal growth has not been examined. Isocaloric protein restriction in pregnant rats, resulted in fetal growth restriction and metabolic reprogramming. Isocaloric protein restriction in the non-pregnant rat, resulted in differential expression of a number of genes in the liver, a 50% increase in whole body serine biosynthesis and high rate of transmethylation, suggesting high methylation demands. These responses were associated with a significant decrease in intracellular taurine levels in the liver suggesting a role of cellular osmolarity in the observed metabolic responses. These unique changes in methionine and one carbon metabolism in response to physiological, nutritional and hormonal influences make these processes critical for cellular and organ function and growth.

Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev. 2006;27(2):141–69.PubMedCrossRef

Fowden AL, Forhead AJ. Endocrine regulation of feto-placental growth. Horm Res. 2009;72(5):257–65.PubMedCrossRef

Godfrey KM. Maternal regulation of fetal development and health in adult life. Eur J Obstet Gynecol Reprod Biol. 1998;78(2):141–50.PubMedCrossRef

HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453–9.CrossRef

Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care. 2009;32(9):1639–43.PubMedCrossRef

Higgins M, Mc Auliffe F. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev. 2010;6(2):116–25.PubMedCrossRef

Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002;99(3):490–6.PubMedCrossRef

Pardi G, Marconi AM, Cetin I. Placental-fetal interrelationship in IUGR fetuses—a review. Placenta. 2002;23(Suppl A):S136–41.PubMedCrossRef

Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr. 2006;136(6 Suppl):1636S–40S.PubMed

10.

Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr. 2004;24:539–77.PubMedCrossRef

11.

Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217–46.PubMedCrossRef

12.

Gregory 3rd JF, Cuskelly GJ, Shane B, Toth JP, Baumgartner TG, Stacpoole PW. Primed, constant infusion with [2H3]serine allows in vivo kinetic measurement of serine turnover, homocysteine remethylation, and transsulfuration processes in human one-carbon metabolism. Am J Clin Nutr. 2000;72(6):1535–41.PubMed

13.

Lamers Y, Williamson J, Theriaque DW, Shuster JJ, Gilbert LR, Keeling C, Stacpoole PW, Gregory 3rd JF. Production of 1-carbon units from glycine is extensive in healthy men and women. J Nutr. 2009;139(4):666–71.PubMedCrossRef

14.

Jacobs RL, Stead LM, Brosnan ME, Brosnan JT. Hyperglucagonemia in rats results in decreased plasma homocysteine and increased flux through the transsulfuration pathway in liver. J Biol Chem. 2001;276(47):43740–7.PubMedCrossRef

15.

Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP, Brosnan JT. Hormonal regulation of cystathionine beta-synthase expression in liver. J Biol Chem. 2002;277(45):42912–8.PubMedCrossRef

16.

Kalhan SC. Metabolism of methionine in vivo: impact of pregnancy, protein restriction, and fatty liver disease. Nestle Nutr Workshop Ser Pediatr Program. 2009;63:121–31. discussion 131–3, 259–68.PubMedCrossRef

17.

Kalhan SC. Fatty acids, insulin resistance, and protein metabolism. J Clin Endocrinol Metab. 2009;94(8):2725–7.PubMedCrossRef

18.

Gelfand RA, Barrett EJ. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest. 1987;80(1):1–6.PubMedCrossRef

19.

Cattaneo M. Homocysteine and the risk of intrauterine growth retardation. Clin Chem. 2003;49(9):1432–3.PubMedCrossRef

20.

Eskes TK. Homocysteine and human reproduction. Clin Exp Obstet Gynecol. 2000;27(3–4):157–67.PubMed

21.

Velzing-Aarts FV, Holm PI, Fokkema MR, van der Dijs FP, Ueland PM, Muskiet FA. Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy. Am J Clin Nutr. 2005;81(6):1383–9.PubMed

22.

Friesen RW, Novak EM, Hasman D, Innis SM. Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. J Nutr. 2007;137(12):2641–6.PubMed

23.

Molloy AM, Mills JL, Cox C, Daly SF, Conley M, Brody LC, Kirke PN, Scott JM, Ueland PM. Choline and homocysteine interrelations in umbilical cord and maternal plasma at delivery. Am J Clin Nutr. 2005;82(4):836–42.PubMed

24.

Seghieri G, Breschi MC, Anichini R, De Bellis A, Alviggi L, Maida I, Franconi F. Serum homocysteine levels are increased in women with gestational diabetes mellitus. Metabolism. 2003;52(6):720–3.PubMedCrossRef

25.

Patrick TE, Powers RW, Daftary AR, Ness RB, Roberts JM. Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension. 2004;43(6):1279–82.PubMedCrossRef

26.

Jansson T. Novel mechanism causing restricted fetal growth: does maternal homocysteine impair placental amino acid transport? J Physiol. 2009;587(Pt 17):4123.PubMedCrossRef

27.

Tsitsiou E, Sibley CP, D'Souza SW, Catanescu O, Jacobsen DW, Glazier JD. Homocysteine transport by systems L, A and y+L across the microvillous plasma membrane of human placenta. J Physiol. 2009;587(Pt 16):4001–13.PubMedCrossRef

28.

Tsitsiou E, Sibley CP, D'Souza SW, Catanescu O, Jacobsen DW, Glazier JD. Homocysteine is transported by the microvillous plasma membrane of human placenta. J Inherit Metab Dis. 2011;34(1):57–65.PubMedCrossRef

29.

Dasarathy J, Gruca LL, Bennett C, Parimi PS, Duenas C, Marczewski S, Fierro JL, Kalhan SC. Methionine metabolism in human pregnancy. Am J Clin Nutr. 2010;91(2):357–65.PubMedCrossRef

30.

Stead LM, Jacobs RL, Brosnan ME, Brosnan JT. Methylation demand and homocysteine metabolism. Adv Enzym Regul. 2004;44:321–33.CrossRef

31.

Levonen AL, Lapatto R, Saksela M, Raivio KO. Human cystathionine gamma-lyase: developmental and in vitro expression of two isoforms. Biochem J. 2000;347(Pt 1):291–5.PubMedCrossRef

32.

Kalhan SC, Bier DM. Protein and amino acid metabolism in the human newborn. Annu Rev Nutr. 2008;28:389–410.PubMedCrossRef

33.

Shoob HD, Sargent RG, Thompson SJ, Best RG, Drane JW, Tocharoen A. Dietary methionine is involved in the etiology of neural tube defect-affected pregnancies in humans. J Nutr. 2001;131(10):2653–8.PubMed

34.

Shaw GM, Velie EM, Schaffer DM. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies? Teratology. 1997;56(5):295–9.PubMedCrossRef

35.

Rees WD, Hay SM, Cruickshank M. An imbalance in the methionine content of the maternal diet reduces postnatal growth in the rat. Metabolism. 2006;55(6):763–70.PubMedCrossRef

36.

Loscalzo J. Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology. J Clin Invest. 2009;119(11):3203–5.PubMed

37.

Haulrik N, Toubro S, Dyerberg J, Stender S, Skov AR, Astrup A. Effect of protein and methionine intakes on plasma homocysteine concentrations: a 6-mo randomized controlled trial in overweight subjects. Am J Clin Nutr. 2002;76(6):1202–6.PubMed

38.

Verhoef P, van Vliet T, Olthof MR, Katan MB. A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers. Am J Clin Nutr. 2005;82(3):553–8.PubMed

39.

Thomas B, Gruca LL, Bennett C, Parimi PS, Hanson RW, Kalhan SC. Metabolism of methionine in the newborn infant: response to the parenteral and enteral administration of nutrients. Pediatr Res. 2008;64(4):381–6.PubMedCrossRef

40.

Yamamoto N, Tanaka T, Noguchi T. The effect of a high-protein diet on cystathionine beta-synthase activity and its transcript levels in rat liver. J Nutr Sci Vitaminol (Tokyo). 1996;42(6):589–93.CrossRef

41.

Pacy PJ, Price GM, Halliday D, Quevedo MR, Millward DJ. Nitrogen homeostasis in man: the diurnal responses of protein synthesis and degradation and amino acid oxidation to diets with increasing protein intakes. Clin Sci (Lond). 1994;86(1):103–16.

42.

Felig P, Owen OE, Wahren J, Cahill Jr GF. Amino acid metabolism during prolonged starvation. J Clin Invest. 1969;48(3):584–94.PubMedCrossRef

43.

Ingenbleek Y, Hardillier E, Jung L. Subclinical protein malnutrition is a determinant of hyperhomocysteinemia. Nutrition. 2002;18(1):40–6.PubMedCrossRef

44.

Ingenbleek Y, Young VR. The essentiality of sulfur is closely related to nitrogen metabolism: a clue to hyperhomocysteinaemia. Nutr Res Rev. 2004;17(2):135–51.PubMedCrossRef

45.

Holt Jr LE, Snyderman SE, Norton PM, Roitman E, Finch J. The plasma aminogram in kwashiorkor. Lancet. 1963;2(7322):1342–8.PubMed

46.

Snyderman SE, Holt Jr LE, Nortn PM, Roitman E, Phansalkar SV. The plasma aminogram. I. influence of the level of protein intake and a comparison of whole protein and amino acid diets. Pediatr Res. 1968;2(2):131–44.PubMedCrossRef

47.

Arroyave G, Wilson D, De Funes C, Behar M. The free amino acids in blood plasma of children with kwashiorkor and marasmus. Am J Clin Nutr. 1962;11:517–24.

48.

Kalhan SC, Uppal SO, Moorman JL, Bennett C, Gruca LL, Parimi PS, Dasarathy S, Serre D, Hanson RW. Metabolic and genomic response to dietary isocaloric protein restriction in the rat. J Biol Chem. 2011;286(7):5266–77.PubMedCrossRef

49.

Brosnan JT, Jacobs RL, Stead LM, Brosnan ME. Methylation demand: a key determinant of homocysteine metabolism. Acta Biochim Pol. 2004;51(2):405–13.PubMed

50.

Perla-Kajan J, Twardowski T, Jakubowski H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007;32(4):561–72.PubMedCrossRef

51.

Medina M, Urdiales JL, Amores-Sanchez MI. Roles of homocysteine in cell metabolism: old and new functions. Eur J Biochem. 2001;268(14):3871–82.PubMedCrossRef

52.

Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the hordaland homocysteine study. Am J Clin Nutr. 2000;71(4):962–8.PubMed

53.

Picciano MF. Is homocysteine a biomarker for identifying women at risk of complications and adverse pregnancy outcomes? Am J Clin Nutr. 2000;71(4):857–8.PubMed

54.

Fux R, Kloor D, Hermes M, Rock T, Proksch B, Grenz A, Delabar U, Bucheler R, Igel S, Morike K, Gleiter CH, Osswald H. Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. Am J Physiol Ren Physiol. 2005;289(4):F786–92.CrossRef

55.

Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000;275(38):29318–23.PubMedCrossRef

56.

Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000;71(5 Suppl):1295S–303S.PubMed

57.

Rao S, Yajnik CS, Kanade A, Fall CH, Margetts BM, Jackson AA, Shier R, Joshi S, Rege S, Lubree H, Desai B. Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune maternal nutrition study. J Nutr. 2001;131(4):1217–24.PubMed

58.

Pagán K, Hou J, Goldenberg RL, Cliver SP, Tamura T. Mid-pregnancy serum homocysteine and B-vitamin concentrations and fetal growth. Nutr Res. 2002;22:11330–41.CrossRef

59.

Relton CL, Pearce MS, Parker L. The influence of erythrocyte folate and serum vitamin B12 status on birth weight. Br J Nutr. 2005;93(5):593–9.PubMedCrossRef

60.

Takimoto H, Mito N, Umegaki K, Ishiwaki A, Kusama K, Abe S, Yamawaki M, Fukuoka H, Ohta C, Yoshiike N. Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan. Eur J Nutr. 2007;46(5):300–6.PubMedCrossRef

61.

Watanabe H, Fukuoka H, Sugiyama T, Nagai Y, Ogasawara K, Yoshiike N. Dietary folate intake during pregnancy and birth weight in Japan. Eur J Nutr. 2008;47(6):341–7.PubMedCrossRef

62.

Nilsen RM, Vollset SE, Monsen AL, Ulvik A, Haugen M, Meltzer HM, Magnus P, Ueland PM. Infant birth size is not associated with maternal intake and status of folate during the second trimester in Norwegian pregnant women. J Nutr. 2010;140(3):572–9.PubMedCrossRef

63.

Kordas K, Ettinger AS, Lamadrid-Figueroa H, Tellez-Rojo MM, Hernandez-Avila M, Hu H, Wright RO. Methylenetetrahydrofolate reductase (MTHFR) C677T, A1298C and G1793A genotypes, and the relationship between maternal folate intake, tibial length and infant size at birth. Br J Nutr. 2009;102(6):907–14.PubMedCrossRef

64.

Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L, Guttormsen AB, Joglekar A, Sayyad MG, Ulvik A, Ueland PM. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr. 2001;74(2):233–41.PubMed

65.

Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, Bhat DS, Naik SS, Coyaji KJ, Joglekar CV, Joshi N, Lubree HG, Deshpande VU, Rege SS, Fall CH. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the pune maternal nutrition study. Diabetologia. 2008;51(1):29–38.PubMedCrossRef

66.

Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85(1):193–200.PubMed

67.

Carmel R. Does high folic acid intake affect unrecognized cobalamin deficiency, and how will we know it if we see it? Am J Clin Nutr. 2009;90(6):1449–50.PubMedCrossRef

68.

Smith AD. Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. Am J Clin Nutr. 2007;85(1):3–5.PubMed

69.

Selhub J, Morris MS, Jacques PF. In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. Proc Natl Acad Sci U S A. 2007;104(50):19995–20000.PubMedCrossRef

70.

Scott JM, Weir DG. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet. 1981;2(8242):337–40.PubMedCrossRef

71.

Kramer MS. Effects of energy and protein intakes on pregnancy outcome: an overview of the research evidence from controlled clinical trials. Am J Clin Nutr. 1993;58(5):627–35.PubMed

72.

Kramer MS. Balanced protein/energy supplementation in pregnancy. Cochrane Database Syst Rev. 2000;2(2):CD000032.PubMed

73.

Sloan NL, Lederman SA, Leighton J, Himes JH, Rush D. The effect of prenatal dietary protein intake on birth weight. Nutr Res. 2001;21:129–39.CrossRef

74.

Godfrey K, Robinson S, Barker DJ, Osmond C, Cox V. Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. BMJ. 1996;312(7028):410–4.PubMedCrossRef

75.

Kramer MS, Kakuma R. Energy and protein intake in pregnancy. Cochrane Database Syst Rev. 2003;4(4):CD000032.PubMed

76.

Snoeck A, Remacle C, Reusens B, Hoet JJ. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate. 1990;57(2):107–18.PubMedCrossRef

77.

Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes. 1991;40 Suppl 2:115–20.PubMed

78.

Fernandez-Twinn DS, Wayman A, Ekizoglou S, Martin MS, Hales CN, Ozanne SE. Maternal protein restriction leads to hyperinsulinemia and reduced insulin-signaling protein expression in 21-mo-old female rat offspring. Am J Physiol Regul Integr Comp Physiol. 2005;288(2):R368–73.PubMedCrossRef

79.

Chen JH, Martin-Gronert MS, Tarry-Adkins J, Ozanne SE. Maternal protein restriction affects postnatal growth and the expression of key proteins involved in lifespan regulation in mice. PLoS One. 2009;4(3):e4950.PubMedCrossRef

80.

Sutton GM, Centanni AV, Butler AA. Protein malnutrition during pregnancy in C57BL/6J mice results in offspring with altered circadian physiology before obesity. Endocrinology. 2010;151(4):1570–80.PubMedCrossRef

81.

Kwong WY, Miller DJ, Ursell E, Wild AE, Wilkins AP, Osmond C, Anthony FW, Fleming TP. Imprinted gene expression in the rat embryo-fetal axis is altered in response to periconceptional maternal low protein diet. Reproduction. 2006;132(2):265–77.PubMedCrossRef

82.

Chisari AN, Giovambattista A, Perello M, Spinedi E. Impact of maternal undernutrition on hypothalamo-pituitary-adrenal axis and adipocyte functions in male rat offspring. Endocrine. 2001;14(3):375–82.PubMedCrossRef

83.

Hales CN. Metabolic consequences of intrauterine growth retardation. Acta Paediatr Suppl. 1997;423:184–7. discussion 188.PubMedCrossRef

84.

Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metabol. 2002;13(9):368–73.CrossRef

85.

Warner MJ, Ozanne SE. Mechanisms involved in the developmental programming of adulthood disease. Biochem J. 2010;427(3):333–47.PubMedCrossRef

86.

Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metabol. 2010;21(4):199–205.CrossRef

87.

Hochberg Z, Feil R, Constancia M, Fraga M, Junien C, Carel JC, Boileau P, Le Bouc Y, Deal CL, Lillycrop K, Scharfmann R, Sheppard A, Skinner M, Szyf M, Waterland RA, Waxman DJ, Whitelaw E, Ong K, Albertsson-Wikland K. Child health, developmental plasticity, and epigenetic programming. Endocr Rev. 2011;32(2):159–224.PubMedCrossRef

88.

Rees WD, Hay SM, Brown DS, Antipatis C, Palmer RM. Maternal protein deficiency causes hypermethylation of DNA in the livers of rat fetuses. J Nutr. 2000;130(7):1821–6.PubMed

89.

McNeil CJ, Hay SM, Rucklidge GJ, Reid MD, Duncan GJ, Rees WD. Gene and protein expression profiles in the foetal liver of the pregnant rat fed a low protein diet. Genes Nutr. 2009;4(3):189–94.PubMedCrossRef

90.

Mortensen OH, Olsen HL, Frandsen L, Nielsen PE, Nielsen FC, Grunnet N, Quistorff B. Gestational protein restriction in mice has pronounced effects on gene expression in newborn offspring’s liver and skeletal muscle; protective effect of taurine. Pediatr Res. 2010;67(1):47–53.PubMedCrossRef

91.

Strakovsky RS, Zhou D, Pan YX. A low-protein diet during gestation in rats activates the placental mammalian amino acid response pathway and programs the growth capacity of offspring. J Nutr. 2010;140(12):2116–20.PubMedCrossRef

92.

Chen JH, Tarry-Adkins JL, Matharu K, Yeo GS, Ozanne SE. Maternal protein restriction affects gene expression profiles in the kidney at weaning with implications for the regulation of renal function and lifespan. Clin Sci (Lond). 2010;119(9):373–84.CrossRef

93.

El-Khattabi I, Gregoire F, Remacle C, Reusens B. Isocaloric maternal low-protein diet alters IGF-I, IGFBPs, and hepatocyte proliferation in the fetal rat. Am J Physiol Endocrinol Metab. 2003;285(5):E991–E1000.PubMed

94.

Gomez-Angelats M, Ruiz-Montasell B, Felipe A, Marin JJ, Casado FJ, Pastor-Anglada M. Effect of protein malnutrition on neutral amino acid transport by rat hepatocytes during development. Am J Physiol. 1995;268(2 Pt 1):E368–74.PubMed

95.

Parimi PS, Cripe-Mamie C, Kalhan SC. Metabolic responses to protein restriction during pregnancy in rat and translation initiation factors in the mother and fetus. Pediatr Res. 2004;56(3):423–31.PubMedCrossRef

96.

Rees WD, Hay SM, Buchan V, Antipatis C, Palmer RM. The effects of maternal protein restriction on the growth of the rat fetus and its amino acid supply. Br J Nutr. 1999;81(3):243–50.PubMed

97.

Petrie L, Duthie SJ, Rees WD, McConnell JM. Serum concentrations of homocysteine are elevated during early pregnancy in rodent models of fetal programming. Br J Nutr. 2002;88(5):471–7.PubMedCrossRef

98.

Torres N, Bautista CJ, Tovar AR, Ordaz G, Rodriguez-Cruz M, Ortiz V, Granados O, Nathanielsz PW, Larrea F, Zambrano E. Protein restriction during pregnancy affects maternal liver lipid metabolism and fetal brain lipid composition in the rat. Am J Physiol Endocrinol Metab. 2010;298(2):E270–7.PubMedCrossRef

99.

Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 1998;12(11):949–57.PubMed

100.

Jackson AA, Dunn RL, Marchand MC, Langley-Evans SC. Increased systolic blood pressure in rats induced by a maternal low-protein diet is reversed by dietary supplementation with glycine. Clin Sci (Lond). 2002;103(6):633–9.

101.

Boujendar S, Reusens B, Merezak S, Ahn MT, Arany E, Hill D, Remacle C. Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia. 2002;45(6):856–66.PubMedCrossRef

102.

Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005;135(6):1382–6.PubMed

103.

Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr. 2002;132(8 Suppl):2393S–400S.PubMed

Titel: Methionine, homocysteine, one carbon metabolism and fetal growth
verfasst von: Satish C. Kalhan
Susan E. Marczewski
Publikationsdatum: 01.06.2012
Verlag: Springer US
Erschienen in: Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2012
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-012-9215-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2012

Fetal programming: Maternal nutrition and role of one-carbon metabolism

Guest editorial: Fetal growth restriction and its consequences

Body composition in infants: Evidence for developmental programming and techniques for measurement

Mechanisms affecting neuroendocrine and epigenetic regulation of body weight and onset of puberty: Potential implications in the child born small for gestational age (SGA)

Maternal micronutrient restriction programs the body adiposity, adipocyte function and lipid metabolism in offspring: A review